surmount-1 tirzepatide 15 mg weight loss percent 72 weeks Body reduction in women treated with by reproductive stage: a post hoc analysis from the SURMOUNT program Weight reduction with different doses – Tirzepatide: Breakthrough in Obesity and

Although direct pharmacokinetic interactions between semaglutide and thyroid hormones are not well-documented, the physiological changes resulting from significant weight loss may necessitate adjustments in thyroid hormone dosing

Degraded peptide may lead to a less potent drug without any visible sign of the problem

Registered doctors and patients recommend us

People who might benefit the most from switching from semaglutide to tirzepatide include those who: Havent lost as much weight as they hoped to on semaglutide, or have run into a weight loss plateau Havent reached their target HbA1c levels on semaglutide, or are hoping for further reductions Have another health condition that only tirzepatide is FDA-approved to treat, such as obstructive sleep apnea If semaglutide hasnt been working well for you, it might be worth switching to tirzepatide